EE526 Health Benefits and Cost-Effectiveness Analysis of Early Cervical Cancer Diagnosis in Bulgaria

Cervical cancer (CC) is the second most common cancer among women aged between 15 and 44 in Europe. Annually, nearly 325.3 million women over the age of 15 are at risk of developing CC. Each year approximately 61 072 women are diagnosed with cervical cancer and 25 829 die from the disease. The primary objective of this study was to evaluate the health benefits of early CC diagnosis in Bulgaria.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research